Su Young Kim, M.D., Ph.D., has served as Nurix’s Vice President of Clinical Development since May 2021. Dr. Kim is trained as a pediatric oncologist and has over 14 years of experience in translational and clinical research. Prior to joining Nurix, Dr. Kim was the clinical lead for venetoclax in chronic lymphocytic leukemia at AbbVie following roles of increasing leadership at Bristol-Myers Squibb. Dr. Kim’s training includes a pediatric oncology fellowship at the National Cancer Institute followed by service as an assistant clinical investigator in the Pediatric Oncology Branch of the NIH. Dr. Kim holds a B.A. in English Literature from the University of Chicago, a Ph.D. in Molecular Genetics from the University of Illinois at Chicago, and an M.D. from the University of Chicago.